HomeEquity Bank Hires a Geriatrician to Sell Reverse Mortgages, And That's Actually Progress

Dr. Samir Sinha spent the first two decades of his career telling families that moving an aging parent into long-term care wasn't failure, it was often necessity. Now he's advising Canada's largest reverse mortgage provider on how to help those same families avoid that conversation entirely.

HomeEquity Bank announced in July 2026 that Sinha, Director of Geriatrics at Sinai Health and the University Health Network in Toronto, would join as its first Health and Wellness Advisor. The role marks the first time a major Canadian financial institution has embedded a practicing geriatrician into product strategy for a lending product. It's also a blunt acknowledgment of what the industry has danced around for years: reverse mortgages are no longer primarily about travel and kitchen renovations. They're about funding medical infrastructure in a house so someone doesn't have to leave it.

The real product is the stairlift

HomeEquity's own customer data tells the story. Health and home-care expenses now rank among the top reasons clients access home equity, alongside debt consolidation. The National Institute on Ageing found that 91% of Canadians over 65 intend to stay in their own homes as long as possible. The gap between that intention and the public system's capacity to deliver it is where the product now lives.

Ontario's long-term care waitlists stretch into years. British Columbia's aren't much better. For the upper-middle-class senior who needs help now, the options are stark: private home care at $2,500 to $5,000 per month, or a fall serious enough to force the issue. A reverse mortgage that funds grab bars, a walk-in tub, and twelve months of part-time personal support workers is not lifestyle spending. It's fracture prevention with compound interest attached.

Sinha's presence gives the pitch clinical legitimacy. He was a lead author of Canada's National Long-Term Care Standards. When he talks about aging in place, he's not reading from a brochure, he's describing outcomes he has measured. The cynical read is that HomeEquity is using a white coat to sell debt. The less cynical read is that the industry is finally admitting what it's selling.

What gets left out

The home equity pool among Canadians aged 55 and older sits above $1 trillion as of 2025. That's an enormous private reserve for a healthcare system that can't meet demand. But tapping it has costs the marketing doesn't emphasize.

A reverse mortgage at current rates will compound faster than a traditional home equity line of credit. Over fifteen years, that difference can mean an estate worth half what it would have been. For adult children expecting an inheritance, or counting on it to fund their own retirements, that's not an abstraction. It's a reallocation of family wealth from the next generation to the current one's care costs.

The alternative, though, is often worse. Placement trauma is real. A cognitively intact 78-year-old who fractures a hip and gets moved to institutional care against their will can deteriorate rapidly. Sinha has written about this extensively. The home, modified and supported, often produces better health outcomes than the facility. The question is who pays for the modification.

Canada is settling that question quietly, one borrower at a time, in favor of private funding. Renters get the waitlist. Homeowners get the equity withdrawal. Sinha's role doesn't create that two-tier structure, but it does make it more efficient.

Progress, with a bill attached

Hiring a geriatrician to advise on mortgage products is progress because it treats the home as what it increasingly is for older Canadians: a healthcare delivery site. The industry is finally being honest about what it's financing. Whether that honesty extends to the full actuarial cost of aging in place with leveraged equity is a different question. Sinha can make the clinical case. Someone still has to make the financial one.